NCT00004806View on ClinicalTrials.gov

Phase I Study of Liposome-Mediated Gene Transfer in Patients With Cystic Fibrosis

PHASE1CompletedINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

June 30, 1995

Primary Completion Date

November 30, 2002

Study Completion Date

November 30, 2002

Conditions
Cystic Fibrosis
Interventions
GENETIC

Cystic fibrosis transmembrane conductance regulator

All Listed Sponsors
collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

lead

University of Alabama at Birmingham

OTHER

NCT00004806 - Phase I Study of Liposome-Mediated Gene Transfer in Patients With Cystic Fibrosis | Biotech Hunter | Biotech Hunter